TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Vifor Pharma Nordiska AB
Closing information (x1000 NOK)
| Closing information | 2023/06 | 2021/12 | 2020/12 |
| Turnover |
237,847
|
236,598 | |
| Financial expenses |
720
|
104 | |
| Earnings before taxes |
6,986
|
6,006 | |
| EBITDA |
7,893
|
6,346 | |
| Total assets |
257,995
|
229,586 | |
| Current assets |
257,451
|
228,789 | |
| Current liabilities |
105,892
|
185,647 | |
| Equity capital |
39,953
|
37,549 | |
| - share capital |
195
|
210 | |
| Employees (average) |
46
|
40
|
38 |
Financial ratios
| Fiscal year | 2023/06 | 2021/12 | 2020/12 |
| Solvency |
15.5%
|
16.4% | |
| Turnover per employee |
5,946
|
6,226 | |
| Profit as a percentage of turnover |
2.9%
|
2.5% | |
| Return on assets (ROA) |
3.0%
|
2.7% | |
| Current ratio |
243.1%
|
123.2% | |
| Return on equity (ROE) |
17.5%
|
16.0% | |
| Change turnover |
17,596
|
11,564 | |
| Change turnover % |
78%
|
8%
|
5% |
| Chg. No. of employees |
6
|
2
|
3 |
| Chg. No. of employees % |
15%
|
5%
|
9% |
Total value of public sale
| Fiscal year | 2023/06 | 2021/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.